Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm’s product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Analyst recommendations
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm’s product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Although lentiviral methods exist for generating transgenic monkeys, technical limitations hinder their utility. Here, the authors demonstrate that co-injecting piggyBac components with sperm ...
The steady-state distribution of mRNA counts, P(m), is dependent only on the values of ki/d and ρ/d, i.e. Hence in order to achieve a perfect match between the theoretical and an experimentally ...
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple organs, conventional treatments like surgery, radiation, and chemotherapy ...